Mission Statement
Macquarie Stem Cell Centres of Excellence are prestigious foci of expertise through which high quality researchers and medical practitioners maintain and develop Australia’s international standing in translational stem cell medicine.
Through Macquarie Stem Cell Centres of Excellence, a high level of collaboration occurs between universities and other organisations in Australia and overseas.
- Undertake highly innovative transformational research that aims to achieve international standing in the field of cellular medicine and leads to a significant advancement of capabilities and knowledge;
- Develop relationships and build new networks with major national and international centres and research programs to
- Help strengthen research
- Achieve global competitiveness and
- Gain recognition for Australian cellular medicine
- Establish Centres of such repute in the wider community that they will serve as points of interaction among higher education institutions, governments, industry and the private sector generally.
In Brief
Our autologous stem cell therapy is an extension of fat grafting. The fat cells and connecting collagen are removed leaving purified cells which include stem cells, progenitor and other regenerating cells and growth factors.
We provide minimally manipulated stem cell therapy as a service in the practice of medicine. When we have treated enough cases of each condition to demonstrate its safety and effectiveness we will then collate these as a pilot study that can then form the basis of an ethics committee approved research trial.
We have patients asking us about our connection with Regeneus and the differences with what they do and what we do.
On the 17th of April 2009 I harvested fat from the first patient in Australia to have this prodedure. Regeneus separated the cells and I injected them into the patient. In November and December I treated another six patients. Regeneus separated the cells for me. Followng this pilot study Regeneus have funded an ethics committee approved trial at Royal North Shore Hospital and have now gone on to work with other doctors treating osteoarthritis.
We have continued to research and practice stem cell therapy for multiple illnesses. We are different in that while Regeneus use collagenase to separte the cells we use collagenase, lecithin and ultrasound. This gives as far greater cell numbers than collagenase alone and we have seen an improvement in our results.
Being the first to inject SVF cells from fat and having contineud to actively research and treat patients, we are now the most experienced doctors in Australia.
The links we provide to research articles are for your information only. They should not be taken as an indication that your condition is suitable or will respond to our treatment.
Stem cells and stem cell therapy have been surrounded by Myth and magic. As we have learnt more about stem cells and their use fact has begun to replace Myth and Magic. At Macquarie Stem Cells for many years we have been moving fat and all the cells it contains around the body. This has caused some unexpected changes to skin texture, wrinkles, nerve supply, etc (Fat transfer)
We received a request to show a group of vets how to harvest fat using liposuction. We went to Kuringai Veterinary Hospital and assisted in the harvesting of fat from a dog. The fat was separated with collagenase and injected into the dogs joints. I was very impressed and that began a collaboration with Regeneus, the company doing the cell separations.
After many sleepless nights worrying about performing this procedure on a human, on 16th April 2009 I harvested fat from a lady who had osteoarthritis rheumatoid arthritis and rotator cuff syndrome. Rengeneus separated the cells and I injected them into her knees. She had an outstanding improvement in all her symptoms. She stopped taking her celestone, prednisone, methatrexate and paracetamol. She did have a flare up of the rheumatoid arthritis in her hands and now is taking methatrexate only.
This led to us removing the collagen that joins all the cells together then separating the adipocytes (fat cells) from all the other cells. The remaining cells include stem cells and are referred to collectively as stromal vascular fraction cells (SVF cells). Injecting these cells has given remarkable improvement to osteoarthritis. There has been a strong effect on back pain, rotator cuffsyndrome and rheumatoid arthritis. We have seen some improvement in asthma and will explore this further.
We are now treating MS with some success. Our colleagues around the world are reporting improvements with other neuro degenerative disorders. We are now starting to treat motor neurone disease, parkinsons,stroke damage and other immune disorders.
